Zimbabwe has declined a significant US healthcare agreement valued at 367 million US dollars (£272m) over five years due to the United States' request for confidential information.
This move came to light following a internal memorandum dated December was disclosed, indicating that President Emmerson Mnangagwa believed the agreement was "lopsided".
An official spokesman later explained that the US was demanding access to health data for scientific study and commercial gain but was unwilling to guarantee the benefits from any future treatments.
"We must now begin the difficult and regrettable task of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for continued negotiations to reach a agreement acceptable to both sides so the nation's vital HIV treatment initiative can proceed.
Broader Context
Zimbabwe's decision comes after a comparable situation in Kenya, where a high court blocked a similar deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
After resuming the presidency last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had overseen aid for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost openness and accountability.
As per statements, 16 nations in Africa have so far agreed to these new agreements, constituting over $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration might have yielded extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no corresponding guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"In essence, our country would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be available to our people should a new disease outbreak emerge."
Sovereignty and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending frameworks already set up through the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential pandemics.
"This mechanism is designed to ensure that when a country contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how future co-operation might be structured in a way that respects the independence and dignity of both nations."
Medical Community Response
Medical experts said it acknowledged the government's concerns, but recommended that negotiations should continue since much of the nation's Aids initiatives depended on international support.
"If technical issues arise, such as those involving information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group added.
The halted deal underscores the continuing debate between accepting crucial international aid and protecting a country's data in an increasingly interconnected world.